Comparison of three colloidal gold immunoassays and GeneXpert Carba-R for the detection of Klebsiella pneumoniae bla KPC-2 variants
Journal of Clinical Microbiology · 2024
DOI: 10.1128/jcm.00154-24 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Clinical Microbiology, 2024. Verfasst von Jinghao Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: beta-Lactamases, Klebsiella pneumoniae, Gold Colloid, Klebsiella Infections. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Science and technology innovation action plan of Shanghai, CHINET.
Abstract (Originalsprache)
The increasing use of ceftazidime-avibactam has led to the emergence of a wide range of ceftazidime-avibactam-resistant bla KPC-2 variants. Particularly, the conventional carbapenemase phenotypic assay exhibited a high false-negative rate for KPC-2 variants. In this study, three colloidal gold immunoassays, including the Gold Mountainriver CGI test, Dynamiker CGI test and NG-Test CARBA5, and GeneXpert Carba-R, were used to detect the presence of KPC-2 carbapenemase and its various variants in 42 Klebsiella pneumoniae strains. These strains covered bla KPC-2 (13/42) and 16 other bla KPC-2 variants including bla KPC-12 (1/42), bla KPC-23 (1/42), bla KPC-25 (1/42), bla KPC-33 (6/42), bla KPC-35 (1/42), bla KPC-44 (1/42), bla KPC-71 (1/42), bla KPC-76 (8/42), bla KPC-78 (1/42), bla KPC-79 (1/42), bla KPC-100 (1/42), bla KPC-127 (1/42), bla KPC-128 (1/42), bla KPC-144 (1/42), bla KPC-157 (2/42), and bla KPC-180 (1/42). For KPC-2 strains, all four assays showed 100% negative percentage agreement (NPA) and 100% positive percentage agreement (PPA) with sequencing results. For all 16 KPC-2 variants, GeneXpert Carba-R showed 100% NPA and 100% PPA, and the three colloidal gold immunoassays showed 100% NPA, while the PPAs of the Gold Mountainriver CGI test, Dynamiker CGI test, and NG-Test CARBA5 were 87.5%, 87.5%, and 68.8%, respectively. We also found a correlation between the mutation site in the amino acid of the variants and false-negative results by colloidal gold immunoassays. In conclusion, the GeneXpert Carba-R has been proven to be a reliable method in detecting KPC-2 and its variants, and the colloidal gold immunoassay tests offer a practical and cost-effective approach for their detection. For the sample with a negative result by a colloidal gold immunoassay test but not matching the drug-resistant phenotype, it is recommended to retest using another type of kit or the GeneXpert Carba-R assay, which can significantly improve the accuracy of detection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
- Department of Laboratory Medicine, Huadong Hospital, Fudan University, Shanghai, China.
- Key Laboratory of Clinical Pharmacology of Antibiotics, Ministry of Health, Shanghai, China.
- Joint Laboratory of Hospital & Enterprise for Pathogen Diagnosis of Drug-resistant Bacterial Infections and Innovative Drug R & D, Shanghai, China.
- Department of Laboratory Medicine, GuiPing People's Hospital, Guangxi, China.
ORCID-Profile: Jinghao Zhang, Renru Han, Fupin Hu
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- Science and technology innovation action plan of Shanghai
- CHINET
Zitieren
APA
Zhang, J., Xu, J., Shen, S., Ding, L., Yang, W., Tang, C., Shi, Q., Zhao, H., Guo, Y., Han, R., & Hu, F. (2024). Comparison of three colloidal gold immunoassays and GeneXpert Carba-R for the detection of Klebsiella pneumoniae bla KPC-2 variants. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.00154-24
Vancouver
Zhang J, Xu J, Shen S, Ding L, Yang W, Tang C, et al. Comparison of three colloidal gold immunoassays and GeneXpert Carba-R for the detection of Klebsiella pneumoniae bla KPC-2 variants. Journal of Clinical Microbiology. 2024. doi:10.1128/jcm.00154-24
BibTeX
@article{Zhang2024,
author = {Zhang, Jinghao and Xu, Jieli and Shen, Siquan and Ding, Li and Yang, Weiwei and Tang, Chengkang and Shi, Qingyu and Zhao, Hu and Guo, Yan and Han, Renru and Hu, Fupin},
title = {Comparison of three colloidal gold immunoassays and GeneXpert Carba-R for the detection of Klebsiella pneumoniae bla KPC-2 variants},
journal = {Journal of Clinical Microbiology},
year = {2024},
doi = {10.1128/jcm.00154-24}
}
EUVIMED